529 related articles for article (PubMed ID: 17650668)
1. [Study on control of graft-versus-host disease by blocking CD137-CD137L ligand costimulatory pathway in mice].
Li CH; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):93-7. PubMed ID: 17650668
[TBL] [Abstract][Full Text] [Related]
2. Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.
Xu K; Li C; Pan X; Du B
Int J Hematol; 2007 Jul; 86(1):84-90. PubMed ID: 17675273
[TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis of graft-versus-host disease in mice by chemical modification of graft and OX40-OX40L costimulatory pathway.].
Huang YH; Feng SR; DU B; Xu KL; Pan XY
Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):735-40. PubMed ID: 20137307
[TBL] [Abstract][Full Text] [Related]
4. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
5. [Study of reducing graft-versus-host disease by in vitro blockade of CD40-CD40 ligand co-stimulatory pathway in allogeneic bone marrow transplantation mouse model].
Huang SL; Chen C; Duan LN; Li HW; Wen GM; Li L; Zhan MY; Wei J
Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):290-4. PubMed ID: 12859863
[TBL] [Abstract][Full Text] [Related]
6. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
7. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
[TBL] [Abstract][Full Text] [Related]
8. Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases.
Nozawa K; Ohata J; Sakurai J; Hashimoto H; Miyajima H; Yagita H; Okumura K; Azuma M
J Immunol; 2001 Nov; 167(9):4981-6. PubMed ID: 11673505
[TBL] [Abstract][Full Text] [Related]
9. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
11. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
Wang CL; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
13. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
Ushiyama C; Hirano T; Miyajima H; Okumura K; Ovary Z; Hashimoto H
J Immunol; 1995 Mar; 154(6):2687-96. PubMed ID: 7876541
[TBL] [Abstract][Full Text] [Related]
15. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
16. CD137 ligand prevents the development of T-helper type 2 cell-mediated allergic asthma by interferon-gamma-producing CD8+ T cells.
Polte T; Jagemann A; Foell J; Mittler RS; Hansen G
Clin Exp Allergy; 2007 Sep; 37(9):1374-85. PubMed ID: 17845419
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS
Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
[TBL] [Abstract][Full Text] [Related]
19. Effect of hyperbaric oxygen on acute graft-versus-host disease after allogeneic bone marrow transplantation.
Song XY; Sun LN; Zheng NN; Zhang HP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):623-6. PubMed ID: 18549642
[TBL] [Abstract][Full Text] [Related]
20. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]